These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19596991)

  • 41. 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes.
    Almerighi C; Sinistro A; Cavazza A; Ciaprini C; Rocchi G; Bergamini A
    Cytokine; 2009 Mar; 45(3):190-7. PubMed ID: 19186073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury.
    Rahman M; Zhang S; Chew M; Ersson A; Jeppsson B; Thorlacius H
    Ann Surg; 2009 Nov; 250(5):783-90. PubMed ID: 19806052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evolution of GITRL immune function: murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily.
    Chattopadhyay K; Ramagopal UA; Brenowitz M; Nathenson SG; Almo SC
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):635-40. PubMed ID: 18182486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Production, purification, and characterization of scFv TNF ligand fusion proteins.
    Fick A; Wyzgol A; Wajant H
    Methods Mol Biol; 2012; 907():597-609. PubMed ID: 22907375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases.
    Xie JH; Yamniuk AP; Borowski V; Kuhn R; Susulic V; Rex-Rabe S; Yang X; Zhou X; Zhang Y; Gillooly K; Brosius R; Ravishankar R; Waggie K; Mink K; Price L; Rehfuss R; Tamura J; An Y; Cheng L; Abramczyk B; Ignatovich O; Drew P; Grant S; Bryson JW; Suchard S; Salter-Cid L; Nadler S; Suri A
    J Immunol; 2014 May; 192(9):4083-92. PubMed ID: 24670803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity.
    Thiemann M; Richards DM; Heinonen K; Kluge M; Marschall V; Merz C; Redondo Müller M; Schnyder T; Sefrin JP; Sykora J; Fricke H; Gieffers C; Hill O
    Front Oncol; 2018; 8():387. PubMed ID: 30298117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgene.
    Fernandes MS; Gomes EM; Butcher LD; Hernandez-Alcoceba R; Chang D; Kansopon J; Newman J; Stone MJ; Tong AW
    Clin Cancer Res; 2009 Aug; 15(15):4847-56. PubMed ID: 19622582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
    Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
    J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.
    Sivasankaran B; Degen M; Ghaffari A; Hegi ME; Hamou MF; Ionescu MC; Zweifel C; Tolnay M; Wasner M; Mergenthaler S; Miserez AR; Kiss R; Lino MM; Merlo A; Chiquet-Ehrismann R; Boulay JL
    Cancer Res; 2009 Jan; 69(2):458-65. PubMed ID: 19147558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor targeting properties of antibody fusion proteins based on different members of the murine tumor necrosis superfamily.
    Hemmerle T; Hess C; Venetz D; Neri D
    J Biotechnol; 2014 Feb; 172():73-6. PubMed ID: 24384233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regression of established AB1 murine mesothelioma induced by peritumoral injections of CpG oligodeoxynucleotide either alone or in combination with poly(I:C) and CD40 ligand plasmid DNA.
    Stone GW; Barzee S; Snarsky V; Santucci C; Tran B; Kornbluth RS
    J Thorac Oncol; 2009 Jul; 4(7):802-8. PubMed ID: 19550243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble CD40L activates soluble and cell-surface integrin αvβ3, α5β1, and α4β1 by binding to the allosteric ligand-binding site (site 2).
    Takada YK; Shimoda M; Maverakis E; Felding BH; Cheng RH; Takada Y
    J Biol Chem; 2021; 296():100399. PubMed ID: 33571526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death.
    Brunekreeft KL; Strohm C; Gooden MJ; Rybczynska AA; Nijman HW; Grigoleit GU; Helfrich W; Bremer E; Siegmund D; Wajant H; de Bruyn M
    Mol Cancer; 2014 Apr; 13():85. PubMed ID: 24741998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced in vitro refolding of soluble human glucocorticoid-induced TNF receptor-related ligand.
    Kovács E; Szilágyi L; Koncz G; Lányi S; Ábrahám B
    Appl Biochem Biotechnol; 2013 Jun; 170(4):819-30. PubMed ID: 23613116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient immobilization of a ligand antibody with high antigen-binding activity by use of a polystyrene-binding peptide and an intelligent microtiter plate.
    Kumada Y; Hamasaki K; Shiritani Y; Ohse T; Kishimoto M
    J Biotechnol; 2009 Jun; 142(2):135-41. PubMed ID: 19501265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD70 represents the human ligand for CD27.
    Hintzen RQ; Lens SM; Koopman G; Pals ST; Spits H; van Lier RA
    Int Immunol; 1994 Mar; 6(3):477-80. PubMed ID: 8186199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ligand-receptor-G-protein molecular assemblies on beads for mechanistic studies and screening by flow cytometry.
    Simons PC; Shi M; Foutz T; Cimino DF; Lewis J; Buranda T; Lim WK; Neubig RR; McIntire WE; Garrison J; Prossnitz E; Sklar LA
    Mol Pharmacol; 2003 Nov; 64(5):1227-38. PubMed ID: 14573773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours.
    Piao J; Kamimura Y; Iwai H; Cao Y; Kikuchi K; Hashiguchi M; Masunaga T; Jiang H; Tamura K; Sakaguchi S; Azuma M
    Immunology; 2009 Aug; 127(4):489-99. PubMed ID: 19604302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transglutaminase-catalyzed covalent multimerization of Camelidae anti-human TNF single domain antibodies improves neutralizing activity.
    Plagmann I; Chalaris A; Kruglov AA; Nedospasov S; Rosenstiel P; Rose-John S; Scheller J
    J Biotechnol; 2009 Jun; 142(2):170-8. PubMed ID: 19439388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.